Company news
Nykode Therapeutics ASA news in 2026
Nykode Therapeutics ASA's news releases, calls and decks from 2026, newest first.
Nykode Therapeutics Receives New U.S. Patent Strengthening Intellectual Property Protection for its fully individualized VB10.NEO cancer vaccine program
August 20, 2026
Q1 2026 Financial Results Q1 2026 Webcast presentation
May 27, 2026
Q1 2026 Financial Results Nykode Q1 2026 Report
May 27, 2026
Nykode Therapeutics reports Q1 2026 Financial Results
May 27, 2026
Nykode Therapeutics - Quarterly Report Q1 2026
May 27, 2026
Invitation to Q1 2026 Financial Results Presentation
May 18, 2026
Nykode Therapeutics - Invitation to Q1 2026 Financial Results Presentation
May 18, 2026
Q4 2025 Financial Results Q4 2025 Webcast presentation
February 27, 2026
Nykode Therapeutics reports Q4 2025 Financial Results
February 25, 2026
Q4 2025 Financial Results Nykode Q4 2025 Report
February 25, 2026
Nykode Therapeutics - Quarterly Report Q4 2025
February 25, 2026
Nykode Therapeutics - Invitation to Q4 2025 Financial Results Presentation
February 11, 2026
Calls in 2026
Decks in 2026
- H.C. Wainwright 28th Annual Global Investment Conference 2026
Conference · 27 slides · Sep 16, 2026
- Q2 2026 Earnings Presentation
Earnings · 28 slides · Aug 26, 2026
- Investor Presentation (August 2026)
Investor deck · 73 slides · August 2026
- Q1 2026 Earnings Presentation
Earnings · 27 slides · May 27, 2026
- Q1 2026 Earnings Presentation
Earnings · 67 slides · May 27, 2026
- DNB Carnegie's Nordic Healthcare Conference 2026
Conference · 32 slides · Mar 10, 2026
- Q4 2025 Earnings Presentation
Earnings · 31 slides · Feb 25, 2026
- Q4 2025 Earnings Presentation
Earnings · 27 slides · Feb 25, 2026
- Investor Presentation (January 2026)
Investor deck · 93 slides · January 2026